These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 36383273)

  • 21. A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe.
    Dietrich JJ; Ahmed N; Webb EL; Tshabalala G; Hornschuh S; Mulaudzi M; Atujuna M; Stranix-Chibanda L; Nematadzira T; Ssemata AS; Muhumuza R; Seeley J; Bekker LG; Weiss HA; Martinson N; Fox J;
    J Int AIDS Soc; 2022 Aug; 25(8):e25975. PubMed ID: 36002910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France).
    Coulaud PJ; Sagaon-Teyssier L; M'madi Mrenda B; Maradan G; Mora M; Bourrelly M; Dembélé Keita B; Keita AA; Anoma C; Babo Yoro SA; Dah TTE; Coulibaly C; Mensah E; Agbomadji S; Bernier A; Couderc C; Laurent C; Spire B;
    Trop Med Int Health; 2018 Oct; 23(10):1084-1091. PubMed ID: 30055043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strengthening health system's capacity for pre-exposure prophylaxis for adolescent girls and young women and adolescent boys and young men in South Africa (SHeS'Cap-PrEP): Protocol for a mixed methods study in KwaZulu-Natal, South Africa.
    Nicol E; Ramraj T; Hlongwa M; Basera W; Jama N; Lombard C; McClinton-Appollis T; Govindasamy D; Pass D; Funani N; Aheron S; Paredes-Vincent A; Drummond J; Cheyip M; Dladla S; Bedford J; Mathews C
    PLoS One; 2022; 17(3):e0264808. PubMed ID: 35298487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV Preexposure Prophylaxis Among Adolescents in the US: A Review.
    Yusuf H; Fields E; Arrington-Sanders R; Griffith D; Agwu AL
    JAMA Pediatr; 2020 Nov; 174(11):1102-1108. PubMed ID: 32391878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-exposure prophylaxis for South African adolescents: What evidence?
    Bekker LG; Gill K; Wallace M
    S Afr Med J; 2015 Nov; 105(11):907-11. PubMed ID: 26632316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "The Time Has Arrived": Perceptions of Behavioral Adjustments in the Context of Pre-Exposure Prophylaxis Availability Among Adolescents in South Africa.
    Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
    AIDS Educ Prev; 2018 Dec; 30(6):463-473. PubMed ID: 30966763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania.
    Tubert J; Packel L; Hunter LA; Mfaume R; Njau P; Ramadhani AA; Liu JX; McCoy SI
    AIDS Res Ther; 2021 Apr; 18(1):21. PubMed ID: 33902623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Awareness of and willingness to use PrEP among Black and Latinx adolescents residing in higher prevalence areas in the United States.
    Taggart T; Liang Y; Pina P; Albritton T
    PLoS One; 2020; 15(7):e0234821. PubMed ID: 32628674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa.
    Beesham I; Dovel K; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
    AIDS Behav; 2022 Sep; 26(9):3079-3087. PubMed ID: 35316471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low awareness and use of pre-exposure prophylaxis among adolescents and young adults in high HIV and sexual violence prevalence settings.
    Ajayi AI; Mudefi E; Yusuf MS; Adeniyi OV; Rala N; Goon DT
    Medicine (Baltimore); 2019 Oct; 98(43):e17716. PubMed ID: 31651904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence.
    Moran A; Mashele N; Mvududu R; Gorbach P; Bekker LG; Coates TJ; Myer L; Joseph Davey D
    AIDS Behav; 2022 Jan; 26(1):205-217. PubMed ID: 34287756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa.
    Muhumuza R; Ssemata AS; Kakande A; Ahmed N; Atujuna M; Nomvuyo M; Bekker LG; Dietrich JJ; Tshabalala G; Hornschuh S; Maluadzi M; Chibanda-Stranix L; Nematadzira T; Weiss HA; Nash S; Fox J; Seeley J
    Arch Sex Behav; 2021 May; 50(4):1729-1742. PubMed ID: 33954824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
    Poteat T; Malik M; van der Merwe LLA; Cloete A; Adams D; Nonyane BAS; Wirtz AL
    Lancet HIV; 2020 Dec; 7(12):e825-e834. PubMed ID: 32622370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Four years later: Do South Africans know what pre-exposure prophylaxis for HIV is?
    Haffejee F; Fasanmi-Kana O; Ally F; Thandar Y; Basdav J
    AIDS Care; 2023 Apr; 35(4):466-473. PubMed ID: 35109735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications for PrEP Uptake in Young Adults Experiencing Homelessness: A Mixed Methods Study.
    Santa Maria D; Gallardo KR; Narendorf S; Petering R; Barman-Adhikari A; Flash C; Hsu HT; Shelton J; Ferguson K; Bender K
    AIDS Educ Prev; 2019 Feb; 31(1):63-81. PubMed ID: 30742477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding PrEP Acceptability Among Priority Populations: Results from a Qualitative Study of Potential Users in Central Uganda.
    Sundararajan R; Wyatt MA; Muwonge TR; Pisarski EE; Mujugira A; Haberer JE; Ware NC
    AIDS Behav; 2022 Aug; 26(8):2676-2685. PubMed ID: 35133529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
    Celum CL; Bukusi EA; Bekker LG; Delany-Moretlwe S; Kidoguchi L; Omollo V; Rousseau E; Travill D; Morton JF; Mogaka F; O'Malley G; Barnabee G; van der Straten A; Donnell D; Parikh UM; Kudrick L; Anderson PL; Haberer JE; Wu L; Heffron R; Johnson R; Morrison S; Baeten JM;
    J Int AIDS Soc; 2022 Jul; 25(7):e25962. PubMed ID: 35822945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical Trial.
    Beesham I; Joseph Davey DL; Beksinska M; Bosman S; Smit J; Mansoor LE
    AIDS Behav; 2022 Aug; 26(8):2623-2631. PubMed ID: 35122575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Next-Generation HIV Pre-Exposure Prophylaxis Preferences Among Men Who Have Sex with Men Taking Daily Oral Pre-Exposure Prophylaxis.
    Ellison J; van den Berg JJ; Montgomery MC; Tao J; Pashankar R; Mimiaga MJ; Chan PA
    AIDS Patient Care STDS; 2019 Nov; 33(11):482-491. PubMed ID: 31603712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.